BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
Holding BVAXF?
Track your performance easily

BioVaxys Technology (BVAXF) Income Statement

29 Followers

BioVaxys Technology Income Statement

Last quarter (Q1 2024), BioVaxys Technology's total revenue was C$―, a decrease of ― from the same quarter last year. In Q1, BioVaxys Technology's net income was C$-542.39K. See BioVaxys Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Oct 23Oct 22Oct 21Oct 20Oct 19
Total Revenue
-----C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 5.67MC$ 6.45MC$ 4.08MC$ 6.44MC$ 1.10MC$ 216.67K
Operating Income
C$ -5.67MC$ -6.45MC$ -4.08MC$ -6.44MC$ -1.10MC$ -216.67K
Net Non Operating Interest Income Expense
C$ 18.60KC$ 24.85KC$ 15.77KC$ -7.66KC$ -137.00C$ 0.00
Other Income Expense
C$ -558.37KC$ 1.27MC$ 7.64MC$ -23.56KC$ -4.38KC$ -209.00
Pretax Income
C$ -5.27MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10MC$ -216.88K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -5.27MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17MC$ -230.12K
Basic EPS
C$ -0.04C$ -0.06C$ -0.12C$ -0.08C$ -0.04C$ -0.02
Diluted EPS
C$ -0.04C$ -0.06C$ -0.12C$ -0.08C$ -0.04C$ -0.02
Basic Average Shares
C$ 645.56MC$ 134.14MC$ 98.18MC$ 82.93MC$ 28.21MC$ 10.39M
Diluted Average Shares
C$ 645.56MC$ 134.14MC$ 98.18MC$ 82.93MC$ 28.21MC$ 10.39M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 5.67MC$ 6.45MC$ 4.08MC$ -6.44MC$ -1.10MC$ 216.67K
Interest Expense
------
Net Income From Continuing And Discontinued Operation
C$ -5.27MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.17MC$ -230.12K
Normalized Income
C$ -3.21MC$ -4.21MC$ -1.22MC$ -4.75MC$ -810.43KC$ -216.67K
EBIT
C$ -5.27MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10MC$ -216.67K
EBITDA
C$ -5.27MC$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10MC$ -216.67K
Currency in CAD

BioVaxys Technology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis